T1	Intervention 495 564	lapatinib plus vinorelbine, compared with lapatinib plus capecitabine
T2	Intervention 699 846	lapatinib plus vinorelbine [(N = 75) 1,250 mg orally once daily (QD) continuously plus 20 mg/m(2)/day intravenously] or lapatinib plus capecitabine
T3	Intervention 857 929	1,250 mg orally QD continuously plus 2,000 mg/m(2)/day orally, 2 doses].
